The Great Lip Injection Debate: Vertical vs. Horizontal
There's a quiet war being waged in the world of aesthetic medicine. It's not about which filler brand is best, or which technique lifts a cheek the most elegantly. It's about a single, deceptively simple question: when you inject the lip, which path is safer for your patient—a vertical injection, crossing the vermilion border at right angles, or a horizontal injection, running parallel to it?
I've seen this debate split the industry. Famous injectors, each with legions of followers, stand on opposite sides. My own audience on social media was almost perfectly divided: 55% said vertical was riskier, 45% disagreed. On Facebook, it was 51% to 49%. Confusion reigns. This lack of consensus tells me something important: our mental models of the lip—the three-dimensional image we hold in our minds when we inject—are often low-resolution, oversimplified, or just plain wrong. And I include my own mental model in that.
So let's clear the fog. This isn't about advocating for a particular technique. I'm not here to say those over-treated "devil lips" are the result of vertical injections. I'm not comparing treatment plans of fifty injections versus one. I want to purify the issue down to its essence: the angle of the needle and the anatomy it encounters. Every intervention is a balance of benefit and harm. A good injector constantly weighs those scales. The goal is to understand the three-dimensional anatomy so well that you can make the safest choice for each unique patient, in each unique moment.
Two Factors, One Governing Principle
To tackle this, I see two factors and one core principle. The first factor is the likely anatomy of the labial artery in the average patient. The second is the precise nature of the injections we are comparing. The governing principle is this: the riskiest injection is the one where the needle deposits the most product closest to the likely position of the artery.
I use the word "likely" deliberately. Injecting is probabilistic. We don't know exactly where the artery is in every patient. We know where it tends to be. Think of the artery like a cloud of electrons around a nucleus—a probability cloud. We inject based on where the probability is highest, and then we try to avoid that zone.
Where the Artery Lives
The superior labial artery usually runs above or within the vermilion border, beneath the orbicularis oris muscle. Studies show it's beneath the muscle about 60% of the time, within the muscle about 35% of the time, and above it only about 5% of the time. It can even wiggle within the same patient. And yes, there are anomalies. A "caliber persistent artery" can appear near the wet-dry border—a known anomaly found in about 2-3% of people. But that's the exception. The normal position, the one we should expect, is just deep to the orbicularis oris muscle.
Picture a cross-section of the lip. The muscle runs down the middle. Anterior to it is a bit of hypodermic fat, then the dermis. Posterior to the muscle, underneath it, is where the artery usually lies. Now, your injection—whether vertical or horizontal—is almost always on the anterior surface of the lip. That's the key.
Comparing Like with Like
To make a fair comparison, I have to keep everything else constant. Same entry point (on the pink part of the lip, not through the white lip), same depth, same volume, same product, same single injection. This is crucial because some people picture a vertical injection that goes through the white lip, right where the artery is—that's a different technique entirely. The modern vertical injection, as practiced by many skilled injectors, enters through the pink lip, skirting superficially. It's a superficial injection that avoids the deep part of the lip, progressively moving away from the likely position of the artery as the needle goes deeper.
A horizontal injection, by contrast, runs right over and adjacent to the artery. It stays in that plane for the entire journey. Even if you're superficial, you're spending more time near the artery. And if there's an anomalous little loop of the artery, a horizontal injection is more likely to snag it.
A Thought Experiment
Imagine you wanted to purposely cannulate the labial artery. How would you do it? I would enter parallel to the artery, because the artery runs from lateral to medial across the lip. I'd go deep, under the orbicularis oris, and poke around until I got a flashback. It would make no sense to enter vertically—that would decrease the chance of hitting the lumen. This simple thought experiment confirms for me that, in a young patient with normal anatomy, a horizontal injection is inherently more likely to cause a vascular occlusion than a vertical one.
But here's where my mental model improved. I asked myself: are there circumstances where this might not hold true? The answer is yes, and it comes from understanding how lips change with age.
When the Rules Change
As people age, their lips involute and atrophy. The vermilion part shrinks, sometimes almost disappearing. In a patient with very small or atrophied lips, a vertical injection—even a superficial one—is naturally forced to aim closer to the retro-orbicularis space where the artery sits. The smaller the lip, the closer the needle gets to the danger zone. In that scenario, a vertical injection might actually be riskier.
This doesn't mean you would intuitively use a vertical injection on such a lip. Most clinicians wouldn't. Vertical injections are typically used on already fuller lips to add a little elevation, not for restoration. But it's a powerful insight: the risk profile of the same injection changes with the volume of the tissue. The artery doesn't shrink as much as the fat pads do, so it occupies a relatively larger percentage of the space. This is true all over the face, not just the lips.
Refining Our Mental Model
So what's the takeaway? I don't want to change anyone's technique. I want to change the way we think about the anatomy. The debate between vertical and horizontal is not a simple one. It depends on the patient's anatomy, their age, their volume loss, and the specific goal of the treatment. The riskiest injection is the one that deposits the most product nearest the likely position of the artery—and that position varies.
For a young, full lip, the vertical injection seems safer because it moves away from the artery. For an aged, atrophied lip, the same injection becomes riskier. The horizontal injection, by staying parallel to the artery, carries a consistent but higher risk of engaging the vessel in most patients. But in a patient with very small lips, the horizontal might actually be safer because it remains superficial and away from the deep retro-orbicularis space.
This is the kind of nuanced understanding that separates a good injector from a great one. We don't memorize a single rule. We build a three-dimensional map in our minds that adapts to each patient. And we keep refining that map, knowing that we are all working with low-resolution models that we can always improve.